DiscoverThe Business of Pharmacy Podcast™From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO
From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

Update: 2025-05-19
Share

Description

Can a small biotech change cancer care—and turn a profit? Paul Romness, CEO of OS Therapies, shares how his five-person team took on one of the deadliest pediatric cancers, went public, and might just shake up the system. From biologics to Wall Street, this one’s got it all. Sponsored by Dae Lee of Buchanan.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

Mike Koelzer, Pharmacist